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Use of a Perforated Balloon Catheter to Deliver Concentrated Heparin
Into the Wall of the Normal Canine Artery
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New York, New York
Aperforated catheter was used to deliver either horserad·
ish peroxidase or ftuoresceinated heparin under pressure to
the canine arterial wall. Depth of penetration of the media
by horseradish peroxidase was dependent on perfusion
pressure. At 5 bar pressure for 1 min, the entire media
showed a reaction product for horseradish peroxidase.
Fluoresceinated heparin delivered under the same condi·
tions could be demonstrated to traverse the entire media as
well.
Apressure of 5 bars caused medial necrosis at 48 hafter
perfusion, even when the perfusing solution was saline.
We recently showed (1) that it is possible to deliver horse-
radish peroxidase into canine arterial media by application of
intraluminal pressure for <1 min. The entire wall was
permeable to this protein of 40,000 molecular weight when a
pressure of 500 mm Hg was applied. The catheter used in
that study was designed to create a "chamber" that permit-
ted a given pressure to be exerted on an isolated vascular
segment. Although this catheter allowed the relation be-
tween locally applied pressure and wall permeability to be
determined, its practical use was limited by the free runoff of
perfusing solution into branches arising from the isolated
segment.
A new perforated catheter was devised to deal with this
shortcoming. The impetus for its development came from
the possibility of "treating" localized disease in the vascu-
lature with medication without exposing the entire circula-
tion of the host to the medication. This could be achieved if
a high concentration of the drug was sequestered in a
particular arterial segment after delivery with a transluminal
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(This did not differ from the effect of standard angioplasty
at the same pressure.) However, heparin at 5,000 V!ml did
not cause medial alteration at 48 h when delivered at the
lower pressure of 500 mm Hg. It is feasible to deliver
heparin over 1min in high concentration to the arterial wall
by means of this balloon catheter. This method may permit
the use of commercially prepared heparin in high concen·
tration as an antiproliferative agent to control the problem
of restenosis after angioplasty.
(J Am Coll CardioI1990;15:475-81)
catheter, and was then allowed to achieve the desired effect
locally.
One clinical problem that seems appropriate for such an
approach is restenosis after angioplasty (2). The mechanisms
underlying restenosis, which occurs in 30% of those sub-
jected to the procedure, are not completely clear (3). Prolif-
eration of smooth muscle cells, triggered by the acute injury
of angioplasty, probably plays an important role (4-6).
Control of this process may prevent restenosis.
Heparin offers interesting possibilities as an antiprolifer-
ative agent (7). It consists of a mixture of molecules ranging
from approximately 8,000 to 20,000 daltons molecular
weight. Species of molecules can be isolated that have either
predominantly anticoagulant or antiproliferative activity; the
latter activity tends to be present in the lower molecular
weight species (7). The antiproliferative species of heparin
have been shown to suppress proliferation of vascular
smooth muscle cells both in vitro (7) and in vivo (8) and,
pertinently, to reduce the stenosis that occurs after experi-
mental angioplasty (9). Large doses of nonanticoagulant
heparin fractions have to be infused intravenously to achieve
these experimental beneficial effects (8). To achieve similar
results by infusion of commercial anticoagulant heparin
requires large doses that are likely to cause lethal hemor-
rhage (8) and are therefore not clinically feasible.
The present study was intended to determine 1) if a
perforated balloon can be used to deliver materials into the
0735-1097/90/$3.50
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Figure 1. Streams of liquid under pressure are
spraying from the holes in this perforated
balloon.
arterial wall; and 2) ifcommercially produced heparin can be
delivered into the wall in doses that permit its antiprolifera-
tive activity to prevail without the risk of excessive systemic
anticoagulation.
Methods
Experimental preparation. Mongrel male and female
dogs approximately 20 to 25 kg in weight were used. The
protocol for testing the catheter in the brachial artery was
described in detail elsewhere (1). In all respects, these
studies conformed to the Position of the American Heart
Association on Research Animal Use adopted in 1984. The
animals were anesthetized with phenobarbital sodium (65
mg/ml). Briefly, after exposure of the artery, an arteriotomy
was made to permit retrograde placement of the catheter. In
some long-term experiments, two segments could be studied
in each brachial artery, but usually only one segment per
side was used.
The segment lengths traversed by the porous balloon
were marked with water-insoluble green ink on the adventi-
tial aspect with the balloon catheter in place. In short-term
experiments, the exposed segment was removed immedi-
ately after the pressure application and vessel marking. In
long-term experiments, the arteriotomy was repaired, flow
established and the skin site closed. The animal was treated
with Flocillin (penicillin G) and was killed in most instances
at 48 h after perfusion (but sometimes at 24 or 72 h after
perfusion) and the previously marked segments were re-
moved.
In describing experiments, the pressures listed were
those applied at the syringe attached to the proximal catheter
connection. Monitoring of all infusate pressures was made
continuously over the 60 s pressure application. It quickly
became apparent that most of the pressure applied to the
proximal port of the perforated balloon was used to over-
come resistance in the catheter itself; the porous balloon was
distended to a much lower pressure.
The perforated balloon catheter. The catheter was 4.3
diameter triple lumen and was made of polyvinyl chloride.
The balloon material was polyethylene terephalate, and the
balloon utilized was 2 cm long, with a diameter of 4 mm. Six
longitudinal rows of 50 perforations each were made in radial
lines with a laser technique. These 300 holes were 25 JLm in
size and were placed in the center 12 mm, with a 4 mm of
"hole-free" balloon length at each end. On application of
pressure, many spray streams could be easily appreciated
(Fig. I). In two experiments, rings of arteries were obtained
from both the center "hole-rich" area and the "hole-free"
ends; in all other cases, only the center zone was studied.
Hematoxylin-eosin staining was performed on formalin-
fixed, paraffin-embedded sections of the rings in all experi-
ments.
Short·term experiments: horseradish peroxidase. For
these studies, horseradish peroxidase in a concentration of 1
mg/ml was used and 3,3 diamino-benzidine was used as
substrate to produce a dark brown reaction product in frozen
sections of the arteries as described previously (1). Three
segments each were studied at 2, 3, 4 and 5 bar pressure.
Two additional brachial arteries were removed 24 h after the
perfusion with horseradish peroxidase.
Short·term experiments: heparin. For these experiments,
we used biologically active (anticoagulant) fluoresceinated
heparin (Polysciences) (10), which had an activity level of
170 U/mg. A solution of 5 mg/ml of heparin in normal saline
solution was used. Five experiments were done at 5 bar
pressure. All but one of these experiments were performed
during 60 s of monitored pressure. The single exception was
performed for 20 s, after which a large leak prevented further
study. All arteries were then marked and segments removed.
Long·term experiments: heparin. For these studies, fluo-
resceinated heparin in a concentration of 30 mg/ml was used
(this is approximately equivalent to 5,000 U/ml of heparin
anticoagulant activity) (10). With use of the perforated
catheter, two segments each were studied 24 and 72 h after
perfusion; at 5 bar pressure, five segments were studied 48 h
after perfusion.
In addition, commercially prepared heparin (Elkins-Sinn)
in a concentration of 1,000 or 5,000 U/ml was perfused and
the artery was studied 48 h after perfusion. Six segments
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were studied at 5,000 Vlml and one at 1,000 Vlml-two of
the six studies at 5,000 Vlml were done using the perforated
catheter at 5 bar pressure; four were done at 500 mm Hg
pressure using the original chamber catheter studied earlier
(1) for reasons that will be discussed. For similar reasons,
two additional segments were perfused with fluoresceinated
heparin using the chamber catheter at 500 mm Hg pressure
and were studied 48 h later.
Rings of arterial segments removed after perfusion with
fluoresceinated heparin were snap-frozen at -70°C in meth-
ylbutane and dry ice, and 4 ]Lm frozen sections were
obtained immediately. Sections were then viewed under an
ultraviolet microscope equipped with epiillumination using a
dichroic TK 510 mirror and K 515 suppression filter.
Results
Even when exposed to pressure of up to 5 bars on the
perfusing fluid (either horseradish peroxidase or heparin) for
1 min, sections of wall segments showed no significant
changes on standard hematoxylin-eosin stains.
Short·term experiments: horseradish peroxidase. When
tested ex vivo, the perforated balloon remained flaccid until
2 bar syringe pressure was exerted on the perfusing fluid. At
2 bar pressure, the brown diaminobenzidine reaction prod-
uct was seen to extend into ::;20% of medial thickness (Fig.
2A). In portions of the circumference, no reaction product
was seen.
At 3 bar pressure, dense brown reaction product was seen
at the inner 50% to 75% of the media in the arterial segment
corresponding to the "hole-rich" central portion of the
balloon (Fig. 2B). Sections of wall exposed to the "hole-
free" end zones showed either no or light reaction product in
the inner 20% of the media. At 4 bar perfusion pressure,
about 80% of the medial thickness showed a dense reaction
product, leaving only a small outer rim of unstained media
(Fig.2C).
At 5 bar perfusion pressure, the entire media and inner
adventitia showed a dense brown reaction product (Fig. 2D).
In one instance, the entire adventitia was reactive. When
rings from the arterial wall segment just outside (that is,
beyond) the balloon-distended segment were examined for
presence of horseradish peroxidase, none was detected at
either 4 or 5 bar perfusion pressure. If 24 h was allowed to
elapse between perfusion of two arteries with horseradish
peroxidase at a 4 bar pressure and removal, no brown
reaction product was detected.
In summary, it appeared that, as had been the case for the
two balloon chamber catheter (1), a positive relation be-
tween perfusion pressure and depth of wall penetration by
horseradish peroxidase could be seen in short-term experi-
ments. Of course, in the case of the perforated catheter,
pressures required to distend the balloon and perfuse fluid
through holes greatly exceeded those needed earlier to
infuse horseradish peroxidase into the open "chamber" and
from there into the wall itself.
Short·term experiments: heparin. Because of our desire
to maximally infuse heparin into the arterial wall, a 5 bar
perfusion pressure for a duration of 60 s was chosen. These
conditions resulted in the demonstration of fluorescence
throughout the entire media in three arteries extending to the
inner adventitia in two arteries. The apple-green fluores-
cence was focused strikingly in the nuclei, although diffuse
cytoplasmic fluorescence was noted as well (Fig. 3A). This
effect can be compared with the result when nonfluoresce-
inated heparin was perfused under the same conditions (Fig.
3B).
In a single instance, perfusion lasted only 20 s. Fluores-
cence, which was intense and mainly nuclear in distribution,
was seen only in the inner third of the media; none was seen
in the outer two thirds. Thus, it would appear that both
pressure and duration of perfusion influence the depth of
penetration.
In all instances, loss of perfusion fluid did not exceed 3.5
ml; in most experiments (horseradish peroxidase or hep-
arin), 0.5 to 1.0 ml of fluid volume was lost from the
perfusion syringe over 1 min.
Long·term experiments: heparin. When fluoresceinated
heparin at a concentration of 5,000 Vlml was infused under
a syringe pressure of 5 bars and 24 to 72 h allowed to elapse
with blood flow restored, nuclear fluorescence as seen in the
short-term experiments was confined to the outer 20% to
25% of the media. This was true whether the elapsed period
was 24, 48 or 72 h (Fig. 4A). The inner medial zone showed
a speckled fluorescent appearance at 24 or 48 h with a vague
background of apple-green color. Both the outer nuclear
fluorescence and the inner speckling were barely detectable
at 72 h. The reason for this difference in inner and outer
media fluorescence in long-term studies readily became
apparent on the hematoxylin-eosin stained sections, which
showed necrosis of the inner media and persistence of nuclei
and wall structure in the outer media. Polymorphonuclear
cell infiltration was prominent in the necrotic wall (Fig. 4B).
We attempted to determine if pressure itself or the
fiuoresceinated heparin was responsible for this damage to
the wall. Fluoresceinated heparin infused at the much lower
pressure of 500 mm Hg using the "chamber" catheter also
produced necrosis of the arterial wall. However, commercial
anticoagulant heparin in doses of 5,000 Vlml infused at the
same "low" 500 mm Hg pressure caused no significant
change in the arterial media 48 h later. On the other hand,
when either ordinary saline solution or commercial antico-
agulant heparin (concentration 5,000 VlmI) was infused at 5
bar pressure through the perforated balloon catheter, necro-
sis of at least the inner 65% to 75% of the media was seen on
examination 48 h later. Fewer polymorphonuclear cells
accompanied this type of necrosis than that seen with
fluoresceinated heparin at either 5 bar or 500 mm Hg
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Figure 2. Penetration of horseradish peroxidase into the media of the
canine brachial artery as demonstrated by the dark reaction product.
Arrows indicate adventitial-medial junction; the lumen is to the
right. A, 2 bar pressure; B, 3 bar pressure; C, 4 bar pressure; D, 5
bar pressure. Horizontal lines represent loo ILm. See text for details.
pressure. Finally, normal saline solution was infused at 5bar
pressure through a perforated catheter and the wall appear-
ance was compared 48 h later with that seen after standard
angioplasty carried out on the contralateral artery at 5 bar
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February 1990:475-81
WOLINSKY ET AL.
PERFORATED BALLOON CATHETER DELIVERY OF HEPARIN
479
balloon pressure. Both arteries showed necrosis of 75% of
the inner media, with minimal polymorphonuclear cell infil-
trate.
Thus, either standard angioplasty or high pressure perfo-
rated balloon perfusion causes significant necrosis of arterial
media cells on examination 48 h after balloon inflation.
CommerciallY prepared heparin in concentrations up to
5,000 Vlml does not cause appreciable damage to the arterial
wall 48 h later in the absence of high pressure. However,
fluoresceinated heparin is toxic to arterial medial cells over
the same period, whether delivered at "high" or "low"
pressure.
Discussion
Balloon pressure and wall penetration. The perforated or
porous catheter delivers fluid to the arterial wall in a manner
that allows a predictable relation between syringe pressure
and wall penetration to be observed. Compared with results
found earlier for the two balloon chamber-type system 0), it
seems reasonable to conclude that actual fluid pressure on
the wall is approximately as follows: At 2bar pressure on the
perforated balloon catheter, penetration is very limited and
equivalent to zero pressure (actually up to 50 mm Hg
pressure) on the more direct chamber system. At 3 bar
Figure 3. A, Presence of apple-green fluorescence throughout the
media after perfusion with fluoresceinated heparin (5,000 DIm!) at 5
bar pressure for 1 min. Both nuclear and diffuse cytoplasmic
fluorescence are seen (lumen at top). B, Lack of fluorescence in the
arterial wall after commercially prepared heparin (5,000 DIm!)
perfusion at 5 bar pressure for 1 min. Yellow autofluorescence of
elastin is evident.
pressure, penetration of approximately 50% corresponds to
about 150 mm Hg direct fluid pressure on the wall. At 4 bar,
the equivalent of about 250 to 300 mm Hg fluid pressure is
being exerted, and at 5 bar perfusion pressure on the
perforated balloon system, about 500 mm Hg of direct fluid
pressure is being exerted.
Advantage of local administration. Our studies demon-
strated that biologically active heparin can be delivered to
the arterial media in a 60 s application and can plainly be
shown to be present throughout the media acutely. Demon-
stration of nuclear fluorescence in the outer undamaged
media for up to 48 h is encouraging but the concentration
or activity of the heparin seen is not known. However, the
dose administered by catheter (30 mg/ml) is orders of
magnitude greater than that shown to be necessary to
suppress cell proliferation either in vivo (8) or in vitro (7)
00 to 20 jLg/ml).
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Figure 4. A, Fluorescence of arterial wall 48 h after perfusion with
fluoresceinated heparin at 5 bar pressure for 1 min. Nuclear fluo-
rescence is seen in the outer media (arrows), but the inner wall
shows only a vaguely speckled appearance. H, Routine histologic
examination of wall corresponding to conditions in A. Near total
necrosis of the inner wall is seen with persistence of smooth muscle
nuclei only in the outer media (arrows). Polymorphonuclear cell
infiltration is prominent (hematoxylin-eosin).
Effects of pressure on wall structure. A striking amount of
damage to the arterial lumen media was seen after 5 bar
pressure applied to either the perforated catheter or the
standard angioplasty catheter. However, severe damage to
the media of normal pig carotid artery (11), normal rabbit
iliac artery (12) and normal rabbit aorta (13) has been
reported previously after angioplasty. At least 50% loss of
the medial cells is seen immediately and the wall is rendered
functionally unreactive to vasoconstrictors (12). This early
insult is eventually overcome with repopulation of the media
and eventual exuberant intimal cell growth, seen weeks to
months later (11). Both this cellular proliferation and throm-
bosis at the angioplasty site in response to injury are
probably important factors in the development of restenosis
(2,4).
Heparin and restenosis. Heparin is most effective in sup-
pression of cell proliferation in vivo when given at the time
of the injury and maintained for 3 days. The effect is much
less marked if it is begun 72 h after injury (14). The drug
seems to block events early in the mitogenic response
pathway (15). Recent evidence (9) that the lower molecular
weight antiproliferative heparins can suppress experimental
restenosis adds further plausibility to the notion that, under
proper conditions, heparin is an important modulator of
arterial wall response in vivo. Whether local heparin instil-
lation directly into the vessel wall can achieve this same
result remains to be seen. Local anticoagulation in addition
to local antiproliferation at the injury site may be an added
advantage in view of the likely contribution of thrombosis.
Recent work (16) suggests that, in addition to reducing cell
number, heparin may also reduce connective tissue matrix
production by these cells.
Conclusions. Given the continuing major clinical problem
that restenosis after angioplasty represents, better definition
of the advantages and limitations of our direct approach to
the angioplasty site must be made. This perforated catheter
may also lend itself to use with other agents directed to the
problem of restenosis or other localized vascular diseases.
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